Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

Search Results

747 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Results By Year timeline is not available.
Page 1
Piperacillin-tazobactam versus meropenem for treatment of bloodstream infections caused by third-generation cephalosporin-resistant Enterobacteriaceae: a study protocol for a non-inferiority open-label randomised controlled trial (PeterPen).
Bitterman R, Koppel F, Mussini C, Geffen Y, Chowers M, Rahav G, Nesher L, Ben-Ami R, Turjeman A, Huberman Samuel M, Cheng MP, Lee TC, Leibovici L, Yahav D, Paul M. Bitterman R, et al. Among authors: mussini c. BMJ Open. 2021 Feb 8;11(2):e040210. doi: 10.1136/bmjopen-2020-040210. BMJ Open. 2021. PMID: 33558347 Free PMC article.
Combination therapy for carbapenem-resistant Gram-negative bacteria.
Paul M, Carmeli Y, Durante-Mangoni E, Mouton JW, Tacconelli E, Theuretzbacher U, Mussini C, Leibovici L. Paul M, et al. Among authors: mussini c. J Antimicrob Chemother. 2014 Sep;69(9):2305-9. doi: 10.1093/jac/dku168. Epub 2014 May 28. J Antimicrob Chemother. 2014. PMID: 24872346 Review.
Seven Versus 14 Days of Antibiotic Therapy for Uncomplicated Gram-negative Bacteremia: A Noninferiority Randomized Controlled Trial.
Yahav D, Franceschini E, Koppel F, Turjeman A, Babich T, Bitterman R, Neuberger A, Ghanem-Zoubi N, Santoro A, Eliakim-Raz N, Pertzov B, Steinmetz T, Stern A, Dickstein Y, Maroun E, Zayyad H, Bishara J, Alon D, Edel Y, Goldberg E, Venturelli C, Mussini C, Leibovici L, Paul M; Bacteremia Duration Study Group. Yahav D, et al. Among authors: mussini c. Clin Infect Dis. 2019 Sep 13;69(7):1091-1098. doi: 10.1093/cid/ciy1054. Clin Infect Dis. 2019. PMID: 30535100 Clinical Trial.
Reply to MacFadden and Hanage and to Pallett et al.
Paul M, Yahav D, Mussini C, Leibovici L. Paul M, et al. Among authors: mussini c. Clin Infect Dis. 2019 Sep 13;69(7):1263-1264. doi: 10.1093/cid/ciz105. Clin Infect Dis. 2019. PMID: 30726885 No abstract available.
Reply to De Greef et al.
Yahav D, Mussini C, Leibovici L, Paul M. Yahav D, et al. Among authors: mussini c. Clin Infect Dis. 2020 Jan 2;70(2):351-353. doi: 10.1093/cid/ciz393. Clin Infect Dis. 2020. PMID: 31076747 No abstract available.
Considerations for the optimal management of antibiotic therapy in elderly patients.
Falcone M, Paul M, Tiseo G, Yahav D, Prendki V, Friberg LE, Guerri R, Gavazzi G, Mussini C, Tinelli M; ESCMID Study Group for Infections in the Elderly (ESGIE). Falcone M, et al. Among authors: mussini c. J Glob Antimicrob Resist. 2020 Sep;22:325-333. doi: 10.1016/j.jgar.2020.02.022. Epub 2020 Mar 9. J Glob Antimicrob Resist. 2020. PMID: 32165285 Free article. Review.
Long-term consequences of COVID-19: research needs.
Yelin D, Wirtheim E, Vetter P, Kalil AC, Bruchfeld J, Runold M, Guaraldi G, Mussini C, Gudiol C, Pujol M, Bandera A, Scudeller L, Paul M, Kaiser L, Leibovici L. Yelin D, et al. Among authors: mussini c. Lancet Infect Dis. 2020 Oct;20(10):1115-1117. doi: 10.1016/S1473-3099(20)30701-5. Epub 2020 Sep 1. Lancet Infect Dis. 2020. PMID: 32888409 Free PMC article. No abstract available.
Epidemiology and Risk Factors Associated With Mortality in Consecutive Patients With Bacterial Bloodstream Infection: Impact of MDR and XDR Bacteria.
Santoro A, Franceschini E, Meschiari M, Menozzi M, Zona S, Venturelli C, Digaetano M, Rogati C, Guaraldi G, Paul M, Gyssens IC, Mussini C. Santoro A, et al. Among authors: mussini c. Open Forum Infect Dis. 2020 Sep 30;7(11):ofaa461. doi: 10.1093/ofid/ofaa461. eCollection 2020 Nov. Open Forum Infect Dis. 2020. PMID: 33209951 Free PMC article.
Development of a Risk Prediction Model for Carbapenem-resistant Enterobacteriaceae Infection After Liver Transplantation: A Multinational Cohort Study.
Giannella M, Freire M, Rinaldi M, Abdala E, Rubin A, Mularoni A, Gruttadauria S, Grossi P, Shbaklo N, Tandoi F, Ferrarese A, Burra P, Fernandes R, Aranha Camargo LF, Asensio A, Alagna L, Bandera A, Simkins J, Abbo L, Halpern M, Santana Girao E, Valerio M, Muñoz P, Fernandez Yunquera A, Statlender L, Yahav D, Franceschini E, Graziano E, Morelli MC, Cescon M, Viale P, Lewis R; CRECOOLT study group. Giannella M, et al. Clin Infect Dis. 2021 Aug 16;73(4):e955-e966. doi: 10.1093/cid/ciab109. Clin Infect Dis. 2021. PMID: 33564840
What have we learned from the first to the second wave of COVID-19 pandemic? An international survey from the ESCMID Study Group for Infection in the Elderly (ESGIE) group.
Tiseo G, Yahav D, Paul M, Tinelli M, Gavazzi G, Mussini C, Prendki V, Falcone M. Tiseo G, et al. Among authors: mussini c. Eur J Clin Microbiol Infect Dis. 2022 Feb;41(2):281-288. doi: 10.1007/s10096-021-04377-1. Epub 2021 Nov 13. Eur J Clin Microbiol Infect Dis. 2022. PMID: 34775534 Free PMC article.
747 results